Senate approves measure to align Colorado rescheduling with federal actions for certain Schedule I drugs

DENVER — The Colorado Senate adopted Senate Bill 31 on second reading, a bill intended to align state scheduling with federal rescheduling decisions so that FDA- and DEA-approved treatments classified as Schedule I at the federal level can be lawfully prescribed and dispensed in Colorado.

Senator Rich, speaking for the health committee, described a committee amendment (L1) clarifying that any Schedule I drug approved by the FDA and DEA would be dispensed in Colorado as a prescription drug in the same manner as other prescription drugs. Senator Linstead, a sponsor, added a clarifying amendment (L2) to ensure the bill would not include “natural medicine,” saying the explicit language should reassure constituents and providers.

Advocates argued the bill would reduce redundant state regulatory steps, speed patient access to evidence-based treatments, and avoid conflicting federal-state classifications. Opponents did not press recorded opposition during the floor discussion; committee report and amendments were adopted and the bill ordered for third reading and final passage.

Senator Linstead summarized the intent: "Colorado patients deserve access to the newest and best treatments to treat depression, PTSD, health veterans, anyone who needs care," and asked colleagues for an I vote.

SB31 was ordered engrossed and placed on the calendar for third reading.